Miragen Therapeutics Gains $3.0M More
Boulder-based Miragen Therapeutics, a firm focused on discovery and development of therapies for cardiovascular and muscle disease, has raised $3.0M in a convertible note funding, according to a regulatory filing from the firm. Source of the new funding was not disclosed. According to the filing, the firm is in the midst of raising $6.0M. Miragen has previously raised funding from Amgen Ventures, Atlas Venture, Boulder Venturesm, Broadview Ventures, and The Perierls Foundation. The firm is headed by William S. Marshall.
posted on Wednesday, September 22, 2010 (Link to more information)
Related companies:
Miragen Therapeutics
Related stories:
> miRagen Therapeutics Raises $40M, Goes Public In Reverse Merger
> miRagen Therapeutics Finds $20M
> miRagen Therapeutics In Strategic, Funding Deal With Servier
> Miragen Therapeutics Raises $8M
> miRagen Therapeutics Gets $4M
Techrockies.com Home